Company Filing History:
Years Active: 2021
Title: Innovations in HIV Prophylaxis by Ivana Mabel Massud
Introduction
Ivana Mabel Massud, a distinguished inventor based in Atlanta, GA, has significantly contributed to the field of medical science with her innovative solutions aimed at combating HIV infections. With one patent to her name, her work is pivotal in advancing the therapeutic landscape for individuals exposed to HIV.
Latest Patents
Massud’s notable patent focuses on HIV post-exposure prophylaxis. It details a method involving the use of nucleoside reverse transcriptase inhibitors, nucleotide reverse transcriptase inhibitors, and integrase inhibitors, which are administered after potential exposure to HIV. Specific safeguards include the administration of pharmacologically effective amounts of agents like emtricitabine (FTC), tenofovir alafenamide (TAF), or tenofovir disoproxil fumarate (TDF), combined with the integrase inhibitor elvitegravir (EVG) to inhibit or prevent the infection. In certain scenarios, only one or two doses of these anti-retroviral agents are necessary post-exposure, showcasing a promising approach to HIV treatment.
Career Highlights
Massud's career is marked by her association with the Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services. Her innovative patent illustrates her commitment to public health and to finding effective solutions for pressing medical challenges. This alignment with a governmental body indicates a focus on research aimed at benefiting public health at a national level.
Collaborations
Throughout her career, Ivana Mabel Massud has collaborated with esteemed colleagues such as Jose Gerardo Garcia Lerma and Walid M Heneine. These partnerships reflect a collaborative spirit that is essential in the pursuit of scientific breakthroughs and the development of new medical therapies.
Conclusion
Ivana Mabel Massud is a remarkable inventor whose contributions to HIV post-exposure prophylaxis underscore her dedication to advancing healthcare innovation. With her patented methodology, she plays an essential role in enhancing preventive measures against HIV infection, ultimately reflecting the critical intersection of science, health, and innovation.